Loading...

CardioGenics Holdings Inc

CGNHPNK
HealthcareMedical - Diagnostics & Research
$0.00
$0.00(0.00%)

CardioGenics Holdings Inc (CGNH) Stock Overview

Explore CardioGenics Holdings Inc’s financial performance, market position, analyst ratings, and future outlook.

Stats data is not available for CGNHStats details for CGNH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for CGNHAnalyst Recommendations details for CGNH are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.

CEO

Dr. Yahia Abdul Gawad Ch.B., M.D., MB, MSc.

Employees

4

Headquarters

6295 Northam Drive, Mississauga, ON

Founded

2004

Frequently Asked Questions